Gene Expression Profiling of Paraffin-Embedded Primary Melanoma Using the DASL Assay Identifies Increased Osteopontin Expression as Predictive of Reduced Relapse-Free Survival

C. Conway; A. Mitra; R. Jewell; J. Randerson-Moor; S. Lobo; J. Nsengimana; S. Edward; D. S. Sanders; M. Cook; B. Powell; A. Boon; F. Elliott; F. de Kort; M. A. Knowles; D. T. Bishop; J. Newton-Bishop

doi:10.1158/1078-0432.CCR-09-1631

Gene Expression Profiling of Paraffin-Embedded Primary Melanoma Using the DASL Assay Identifies Increased Osteopontin Expression as Predictive of Reduced Relapse-Free Survival

C. Conway, A. Mitra, R. Jewell, J. Randerson-Moor, S. Lobo, J. Nsengimana, S. Edward, D. S. Sanders, M. Cook, B. Powell, A. Boon, F. Elliott, F. de Kort, M. A. Knowles, D. T. Bishop, J. Newton-Bishop

Research output: Contribution to journal › Article › peer-review

83 Citations (Scopus)

Original language	English
Pages (from-to)	6939
Journal	Clinical Cancer Research
Volume	15
Issue number	22
DOIs	https://doi.org/10.1158/1078-0432.CCR-09-1631
Publication status	Published (in print/issue) - 2009

Access to Document

10.1158/1078-0432.CCR-09-1631

Cite this

Conway, C., Mitra, A., Jewell, R., Randerson-Moor, J., Lobo, S., Nsengimana, J., Edward, S., Sanders, D. S., Cook, M., Powell, B., Boon, A., Elliott, F., de Kort, F., Knowles, M. A., Bishop, D. T., & Newton-Bishop, J. (2009). Gene Expression Profiling of Paraffin-Embedded Primary Melanoma Using the DASL Assay Identifies Increased Osteopontin Expression as Predictive of Reduced Relapse-Free Survival. Clinical Cancer Research, 15(22), 6939. https://doi.org/10.1158/1078-0432.CCR-09-1631

@article{963b6342ea684713a8466dba37e33255,

title = "Gene Expression Profiling of Paraffin-Embedded Primary Melanoma Using the DASL Assay Identifies Increased Osteopontin Expression as Predictive of Reduced Relapse-Free Survival",

author = "C. Conway and A. Mitra and R. Jewell and J. Randerson-Moor and S. Lobo and J. Nsengimana and S. Edward and Sanders, {D. S.} and M. Cook and B. Powell and A. Boon and F. Elliott and {de Kort}, F. and Knowles, {M. A.} and Bishop, {D. T.} and J. Newton-Bishop",

year = "2009",

doi = "10.1158/1078-0432.CCR-09-1631",

language = "English",

volume = "15",

pages = "6939",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research",

number = "22",

}

Conway, C, Mitra, A, Jewell, R, Randerson-Moor, J, Lobo, S, Nsengimana, J, Edward, S, Sanders, DS, Cook, M, Powell, B, Boon, A, Elliott, F, de Kort, F, Knowles, MA, Bishop, DT & Newton-Bishop, J 2009, 'Gene Expression Profiling of Paraffin-Embedded Primary Melanoma Using the DASL Assay Identifies Increased Osteopontin Expression as Predictive of Reduced Relapse-Free Survival', Clinical Cancer Research, vol. 15, no. 22, pp. 6939. https://doi.org/10.1158/1078-0432.CCR-09-1631

TY - JOUR

T1 - Gene Expression Profiling of Paraffin-Embedded Primary Melanoma Using the DASL Assay Identifies Increased Osteopontin Expression as Predictive of Reduced Relapse-Free Survival

AU - Conway, C.

AU - Mitra, A.

AU - Jewell, R.

AU - Randerson-Moor, J.

AU - Lobo, S.

AU - Nsengimana, J.

AU - Edward, S.

AU - Sanders, D. S.

AU - Cook, M.

AU - Powell, B.

AU - Boon, A.

AU - Elliott, F.

AU - de Kort, F.

AU - Knowles, M. A.

AU - Bishop, D. T.

AU - Newton-Bishop, J.

PY - 2009

Y1 - 2009

U2 - 10.1158/1078-0432.CCR-09-1631

DO - 10.1158/1078-0432.CCR-09-1631

M3 - Article

VL - 15

SP - 6939

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 22

ER -